Dr. Reddy's Laboratories Files Routine 6-K Report
Ticker: RDY · Form: 6-K · Filed: Jul 25, 2025 · CIK: 1135951
Sentiment: neutral
Topics: sec-filing, compliance, foreign-private-issuer
Related Tickers: RDY
TL;DR
DRL filed a 6-K, just confirming they're a 20-F filer. No new news.
AI Summary
Dr. Reddy's Laboratories Limited filed a Form 6-K on July 25, 2025, confirming it files annual reports under Form 20-F. The filing is a routine report for a foreign private issuer and does not contain specific financial or operational updates beyond its reporting status.
Why It Matters
This filing confirms Dr. Reddy's compliance with SEC reporting requirements for foreign private issuers, ensuring transparency for investors.
Risk Assessment
Risk Level: low — This is a routine administrative filing confirming reporting status and does not contain material non-public information.
Key Players & Entities
- Dr. Reddy's Laboratories Limited (company) — Filer of the report
- Form 6-K (document) — Type of SEC filing
- Form 20-F (document) — Annual report form for foreign private issuers
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, primarily confirming the company's reporting status.
What is the filing date of this report?
The filing date is July 25, 2025.
Does Dr. Reddy's Laboratories file annual reports under Form 20-F or Form 40-F?
Dr. Reddy's Laboratories Limited indicates it files annual reports under cover of Form 20-F.
What is the principal executive office address of Dr. Reddy's Laboratories?
The principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
Is this filing submitted in paper format?
The filing does not explicitly state it is submitted in paper format, but it is a standard electronic filing.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 25, 2025 regarding DR REDDYS LABORATORIES LTD (RDY).